Nishith Rastogi is the CEO and co-founder of Locus, where he leads global strategy, innovation, and product development. He drives the company’s international expansion and oversees its technology ...

In today's Pharmaceutical Executive Daily, Novartis agrees to acquire a pan-mutant-selective inhibitor from Synnovation Therapeutics in a deal worth up to $3 billion while Collegium moves to acquire ...

FDA authorization of semaglutide 7.2 mg once weekly was supported by two 72-week Phase III programs and reviewed under the Commissioner’s National Priority Voucher, shortening standard timelines. STEP ...

This episode of The Ron Lanton Report examines how the relationship between policy and market behavior has fundamentally shifted. Regulatory signals are now moving valuations and shaping strategic ...

Founder, Infinitus, notes the the emerging themes at Access USA 2026, including regulatory shifts, the collapse of the traditional hub model, and the proliferation of fragmented AI point solutions. In ...

Founder, Infinitus, notes the the emerging themes at Access USA 2026, including regulatory shifts, the collapse of the traditional hub model, and the proliferation of fragmented AI point solutions.

Launched in January, TrumpRx.gov is part of a series of most-favored-nation deals struck between the Trump administration and ...

In today's Pharmaceutical Executive Daily, a new analysis finds that TrumpRx is listing prices for roughly a third of its featured drugs higher than what patients in the United Kingdom pay, two ...

Founder, Infinitus touches on the approach to human oversight in an effort to build trust in autonomous patient access workflows by keeping humans and AI in a continuous feedback loop. In a ...

One key failure mechanism is the logistic implementation for the DCT trials. A lot of times, when you go to a global trial, there's a lot of logistic management for DCT. Let's say you must ship the ...

Nominate a colleague with impressive leadership and career intentions – even yourself! – for the Pharmaceutical Executive ...

This is the result of engines not having the full data set, which they won’t have in the full public realm. If employees are using those and that gap exists, it clouds the data. With private LLMs, ...